Stock Market Dr Reddy’s Laboratories shares fall over 2% as USFDA issues Form 483 with… Aditya Bhagchandani Nov 21, 2024
Stock Market Dr. Reddy’s Laboratories shares jump 2% as company clocks highest-ever… Aman Shukla Nov 6, 2024
Corporates Dr. Reddy’s Laboratories launches Elobixibat (BixiBat®) to treat chronic… Aman Shukla Oct 28, 2024
Corporates Dr. Reddy’s Laboratories subsidiary announces promising Phase 1 results for… Aman Shukla Oct 8, 2024
Corporates Dr Reddy’s Laboratories signs licensing deal with Gilead Sciences to… Aman Shukla Oct 2, 2024
Stock Market Dr. Reddy’s Laboratories shares surge 2% following initiation of exclusive… Aditya Bhagchandani Mar 28, 2024
Stock Market Dr. Reddy’s Laboratories records strong Q3 earnings with blockbuster Cancer… Aditya Bhagchandani Jan 31, 2024
Stock Market Dr Reddy’s Laboratories Faces Share Price Dip 6% Amid FDA Observations Aditya Bhagchandani Dec 11, 2023
Stock Market Dr. Reddy’s Laboratories fall 2% on the back of USFDA inspection findings Aditya Bhagchandani Oct 13, 2023
Stock Market Dr Reddy stock dips nearly 1% on the back of antitrust litigation in US over… Aditya Bhagchandani Oct 10, 2023
Stock Market Stocks to watch: Wipro, DMart, HDFC Bank, Piramal Pharmacy, and more Aryan Jakhar Jan 16, 2023
Stock Market Stocks to watch: SBI, Reliance, InterGlobe Aviation, Bank of Baroda, Titan and… Aryan Jakhar Nov 7, 2022
Stock Market Stocks to watch: Vedanta, Adani Green, SBI Cards, Tata Chemicals, Dr Reddy’s… Aryan Jakhar Oct 28, 2022
